Trades on 1 secondary market

Centivax

Centivax is a clinical-stage biotechnology company based in South San Francisco, California, developing broad-spectrum vaccines to prevent infectious diseases at scale. Its lead program is a universal, broadly protective influenza vaccine in Phase 1 clinical development designed to protect against a

minimal 11.9 / 100 0 APIs View provider profile →
CompanyDigital BiologyBiotechnologyVaccinesImmunologyInfectious Disease

Centivax is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.